Pamela Stephenson's Net Worth
$286 Thousand
Who is Pamela Stephenson?
Pamela Stephenson does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include ALBIREO PHARMA, INC., and Zynerba Pharmaceuticals, Inc..
SEC CIK
Pamela Stephenson's CIK is 0001767650
Past Insider Trading and Trends
2019 was Pamela Stephenson's most active year for acquiring shares with 4 total transactions. Pamela Stephenson's most active month to acquire stocks was the month of December. 2023 was Pamela Stephenson's most active year for disposing of shares, totalling 12 transactions. Pamela Stephenson's most active month to dispose stocks was the month of February. 2023 saw Pamela Stephenson paying a total of $0.00 for 229,560 shares, this is the most they've acquired in one year. In 2023 Pamela Stephenson cashed out on 374,623 shares for a total of $82,394.04, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
ALBIREO PHARMA, INC. No price found
Chief Commercial Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -22.24K |
—
|
—
|
0
|
Mar 2
| |||
Form 4/A
| +128.64% | 55K |
—
|
—
| 97.75K |
Jan 19
| |||
Form 4
| +128.64% | 55K |
—
|
—
| 97.75K |
Jan 19
| |||
Form 4
| -0.24% | -102.00 |
$43.80 | -$4,467.60 | 42.76K |
Scheduled
|
Jan 23
| ||
Form 4
| -3.97% | -1.77K |
$43.90 | -$77,886.41 | 42.86K |
Scheduled
|
Jan 19
| ||
Form 4/A
| -1.04% | -469.00 |
$19.06 | -$8,939.80 | 44.63K |
Scheduled
|
Dec 27
| ||
Form 4/A
| -0.23% | -106.00 |
$24.67 | -$2,615.16 | 45.65K |
Scheduled
|
Jul 22
| ||
Form 4
| -1.03% | -469.00 |
$19.06 | -$8,939.80 | 45.18K |
Scheduled
|
Dec 27
| ||
Form 4
| -0.23% | -104.00 |
$19.58 | -$2,035.95 | 45.65K |
Scheduled
|
Oct 24
| ||
Form 4
| -0.96% | -445.00 |
$19.40 | -$8,635.18 | 45.75K |
Scheduled
|
Sep 26
| ||
Form 4
| -0.23% | -106.00 |
$24.67 | -$2,615.16 | 46.2K |
Scheduled
|
Jul 22
| ||
Form 4
| -1.00% | -461.00 |
$19.47 | -$8,975.67 | 45.76K |
Scheduled
|
Jun 27
| ||
Form 4
| -0.22% | -103.00 |
$32.92 | -$3,391.24 | 46.22K |
Scheduled
|
Apr 22
| ||
Form 4
| -0.97% | -454.00 |
$30.52 | -$13,858.35 | 46.32K |
Scheduled
|
Mar 28
| ||
Form 4
| -0.88% | -416.00 |
$24.88 | -$10,351.00 | 46.77K |
Scheduled
|
Jan 24
| ||
Form 4
| +84.41% | 21.6K |
—
|
—
| 47.19K |
Jan 18
| |||
Form 4
| -1.82% | -474.00 |
$23.92 | -$11,339.45 | 25.59K |
Scheduled
|
Dec 27
| ||
Form 4
| -1.70% | -451.00 |
$32.05 | -$14,456.22 | 26.06K |
Scheduled
|
Sep 27
| ||
Form 4
| -1.75% | -471.00 |
$36.01 | -$16,960.71 | 26.51K |
Scheduled
|
Jun 25
| ||
Form 4
| -1.54% | -422.00 |
$34.02 | -$14,355.34 | 26.98K |
Scheduled
|
Mar 29
| ||
Form 4
| +25.11% | 5.5K |
—
|
—
| 27.41K |
Jan 21
| |||
Form 4
| -2.06% | -460.00 |
$39.07 | -$17,974.13 | 21.91K |
Scheduled
|
Dec 28
| ||
Form 4
| -1.98% | -451.00 |
$33.20 | -$14,973.20 | 22.37K |
Scheduled
|
Sep 25
| ||
Form 4
| -1.71% | -397.00 |
$30.79 | -$12,223.63 | 22.82K |
Scheduled
|
Jun 25
| ||
Form 4
| -7.14% | -1.78K |
$17.60 | -$31,416.00 | 23.21K |
Scheduled
|
Mar 25
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 21
| |||
Form 4
|
∞
| 25K |
—
|
—
| 25K |
Mar 25
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Zynerba Pharmaceuticals, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -75.78K |
—
|
—
|
0
|
Oct 10
| |||
Form 4
| +169.97% | 47.71K |
$0.35 | -$40.03 | 75.78K |
Jun 13 - Jun 14
| |||
Form 4
| +461.38% | 23.07K |
$1.01 | -$40.40 | 28.07K |
Jun 14
| |||
Form 4
|
∞
| 5K |
—
|
—
| 5K |
Aug 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 19
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Disc Medicine, Inc. (IRON) No price found
Chief Commercial Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 36.67K |
—
|
—
| 36.67K |
Feb 26
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||